z-logo
Premium
Toll like receptor 2 knock‐out attenuates carbon tetrachloride (CCl 4 )‐induced liver fibrosis by downregulating MAPK and NF‐κB signaling pathways
Author(s) -
Ji Lingling,
Xue Ruyi,
Tang Wenqing,
Wu Weibin,
Hu Tingting,
Liu Xijun,
Peng Xiaomin,
Gu Jianxin,
Chen She,
Zhang Si
Publication year - 2014
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2014.04.042
Subject(s) - tlr2 , proinflammatory cytokine , chemistry , signal transduction , mapk/erk pathway , toll like receptor , nf κb , fibrosis , liver injury , hepatic stellate cell , p38 mitogen activated protein kinases , nfkb1 , cancer research , receptor , tlr4 , innate immune system , inflammation , endocrinology , medicine , biology , transcription factor , biochemistry , gene
Innate immune signaling associated with Toll‐like receptors (TLRs) is a key pathway involved in the progression of liver fibrosis. In this study, we reported that TLR2 is required for hepatic fibrogenesis induced by carbon tetrachloride (CCl 4 ). After CCl 4 treatment, TLR2 −/− mice had reduced liver enzyme levels, diminished collagen deposition, decreased inflammatory infiltration and impaired activation of hepatic stellate cells (HSCs) than wild type (WT) mice. Furthermore, after CCl 4 treatment, TLR2 −/− mice demonstrated downregulated expression of profibrotic and proinflammatory genes and impaired mitogen‐activated protein kinases (MAPK) and nuclear factor kappa B (NF‐κB) activation than WT mice. Collectively, our data indicate that TLR2 deficiency protects against CCl 4 ‐induced liver fibrosis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom